NCT05337683View on ClinicalTrials.gov

A Retrospective Non-Interventional Study to Evaluate the Impact of Eculizumab in Korean PNH Patients

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

December 11, 2020

Primary Completion Date

August 30, 2021

Study Completion Date

January 3, 2022

Conditions
PNH
Trial Locations (1)

Unknown

Handok, Seoul

Sponsors

Lead Sponsor

Handok Inc.
All Listed Sponsors
lead

Handok Inc.

INDUSTRY

NCT05337683 - A Retrospective Non-Interventional Study to Evaluate the Impact of Eculizumab in Korean PNH Patients | Biotech Hunter | Biotech Hunter